CClinicalTrials.gg
Status unknownNCT04913558Updated Jul 27, 2021

Effect of Aerobic Exercise on Stress and Fatigue of Lactating Employed Women

An interventional study of Aerobic exercise and Traditional Treatment in Stress and Fatigue, sponsored by Cairo University. Status unknown at 1 site in Egypt. Open to female participants aged 25 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-07-27.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jul 2021), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
25 Years to 35 Years
Sex
Female
01

Study summary

The study aims to determine the effect of aerobic exercise on stress and fatigue of employed lactating women.

Read the detailed description

The study aims to determine the effect of aerobic exercise on stress and fatigue of employed lactating women. This study will be carried out on Sixty lactating mothers working in the medical field who have returned to work after maternity leave and suffering from stress and fatigue.

The subjects will be divided randomly into two groups equal in number, the Aerobic exercise group ( group A) and the Control group ( group B).

Group A will consist of thirty employed lactating women suffering from stress and fatigue. These women will perform aerobic exercise for 30 minutes for each session, 5 times per week, for 6 weeks in the form of treadmill training (60- 70% of HR max) and do some modifications of their routine by following lifestyle modification advice given to them during the 6 weeks of the program period.

Control group (group B):

This group will consist of thirty employed lactating women suffering from stress and fatigue. This group will receive the same lifestyle modification advice that will be given to group (A) during the six weeks of the program period.

02

Conditions studied

  • Stress
  • Fatigue

Browse trials for

03

In context

Fatigue

1,860 studies on the registry are indexed under Fatigue; 376 are open to participants now.

This study's planned enrollment of 60 is above the median of 54 across 1,440 interventional studies indexed under Fatigue.

Browse Fatigue studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • All participants are lactating mothers.
  • Working in the medical field 4 to 6 hours per day, 4 to 5 days per week.
  • Returned to work after 4 months of maternity leave.
  • Suffering stress and fatigue considering the perceived stress questionnaire and the fatigue assessment scale.
  • Their babies' ages will be ranged from 6 to 8 months old.
  • Having at least one year of work experience before giving birth.
  • Their age will be ranged from 25 to 35 years.
  • They haven't exercised more than twice per week during the previous 3 months.

Exclusion criteria

Exclusion Criteria:

  • Any neurological, cardiovascular disorders, or metabolic disease
  • Physical impairments that prevent following the program.
  • Women who are planning to stop breastfeeding in the next 4 months.
  • Women with regular medications.
  • Mothers of formula feeding babies.
  • women who are smoking will be excluded from this study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Traditional Treatment Arm

    This group will consist of thirty employed lactating women suffering from stress and fatigue. This group will receive the same lifestyle modification advice that will be given to the aerobic exercise group during the six weeks of the program period.

    Other: Traditional Treatment

  • Experimental
    Aerobic exercise group

    This group will consist of thirty employed lactating women suffering from stress and fatigue. These women will perform aerobic exercise for 30 minutes for each session, 5 times per week, for 6 weeks in the form of treadmill training (60- 70% of HR max) and do some modifications of their routine by following lifestyle modification advice given to them during the 6 weeks of the program period.

    Other: Aerobic exercise · Other: Traditional Treatment

Interventions

  • OtherAerobic exercise

    The exercise will be performed by using the treadmill as the following: - The first stage (warming up): It consists of 5 minutes warming up with the treadmill speed set at 1.0 mile per hour. - The second stage (active stage): It consists of 20 minutes with the treadmill speed set at 3.0 miles per hour. - Third stage (cooling down): It consists of 5 minutes of cooling down with the treadmill speed set at 1.0 miles per hour.

  • OtherTraditional Treatment

    1. General advice for reducing fatigue and stress 2. Fluid and diet advice 3. Carrying the Baby 4. While Breastfeeding in a sitting position 5. Selecting Clothing

06

What researchers measure

Primary outcomes

  1. Stress assessment

    Change from baseline of stress at 6 weeks. Assessment of stress through using perceived stress scale 10 will be performed before and after intervention

    Time frame: Baseline and 6 weeks post-intervention

  2. Fatigue assessment

    Change from baseline of stress at 6 weeks. Assessment of fatigue through using fatigue assessment scale will be performed before and after intervention

    Time frame: Baseline and 6 weeks post-intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 27, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04913558
Lead sponsor
Cairo University
Responsible party
Sara Elsayed Basyouny Zaher (Principal Investigator, Cairo University) — Principal investigator
First posted
Jun 4, 2021
Start date
May 1, 2021
Primary completion
Oct 15, 2021 (estimated)
Completion
Nov 30, 2021 (estimated)
Last update
Jul 27, 2021

Study contacts

Sara Zaher
Contact
sara.elsayed.zaher@gmail.com
+201127222726
Sara Zahrer
principal investigator · Cairo University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion